Memory CD8. + T Cells Specific for Minor Histocompatibility Antigen H60 Can Mediate the Graft-Versus-Leukemia Effect.

被引：0
|
作者：
Li, Ning
Matte-Martone, Catherine
Venkatesan, Srividhya
Shlomchik, Warren D.
机构：
[1] Yale Univ, Sch Med, Ctr Canc, New Haven, CT USA
[2] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：545 / 545
页数：1
相关论文
共 50 条
  • [21] Tracking immune responses during GvHD: the H60 histocompatibility antigen dominates the CD8 T cell response
    Choi, EY
    Christianson, G
    Sproule, T
    Yoshimura, Y
    Joyce, S
    Roopenian, D
    FASEB JOURNAL, 2001, 15 (05): : A1197 - A1197
  • [22] Identification of a novel polymorphism in the I domain of CD49b: A candidate minor histocompatibility antigen as a target of graft-versus-leukemia effect on chronic myelogenous leukemia.
    Kondo, Y
    Kotani, T
    Feng, XM
    Shiobara, S
    Nakao, S
    BLOOD, 2001, 98 (11) : 385A - 385A
  • [23] CD4-CD8- regulatory T cells implicated in preventing graft-versus-host and promoting graft-versus-leukemia responses
    Young, KJ
    DuTemple, B
    Zhang, ZX
    Levy, G
    Zhang, L
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1762 - 1763
  • [24] THE ROLE OF CD4 AND CD8 T-CELLS IN THE GRAFT-VERSUS-LEUKEMIA RESPONSE IN RAUSCHER MURINE LEUKEMIA
    OKUNEWICK, JP
    KOCIBAN, DL
    MACHEN, LL
    BUFFO, MJ
    BONE MARROW TRANSPLANTATION, 1991, 8 (06) : 445 - 452
  • [25] DONOR T-CELLS SPECIFIC FOR HEMATOPOIETIC-RESTRICTED MINOR HISTOCOMPATIBILITY ANTIGENS ARE INDUCED IN PATIENTS IN WHICH GRAFT-VERSUS-LEUKEMIA REACTIVITY IS ACCOMPANIED WITH GRAFT-VERSUS-HOST DISEASE
    Pont, M.
    Lurvink, E.
    Van Bergen, C.
    Honders, M.
    van Luxemburg-Heijs, S.
    Kester, M.
    Falkenburg, J.
    Griffioen, M.
    HAEMATOLOGICA, 2012, 97 : 36 - 36
  • [26] Donor T-cells for hematopoietic-restricted minor histocompatibility antigens are induced in patients with combined Graft-versus-Leukemia and Graft-versus-Host disease
    Pont, M. J.
    van Bergen, C. A. M.
    Honders, M. W.
    van Luxemburg-Heijs, S. A. P.
    Kester, M. G. D.
    Falkenburg, J. H. F.
    Griffioen, M.
    HUMAN GENE THERAPY, 2014, 25 (11) : A40 - A40
  • [27] Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant
    Weber, G.
    Gerdemann, U.
    Caruana, I.
    Savoldo, B.
    Hensel, N. F.
    Rabin, K. R.
    Shpall, E. J.
    Melenhorst, J. J.
    Leen, A. M.
    Barrett, A. J.
    Bollard, C. M.
    LEUKEMIA, 2013, 27 (07) : 1538 - 1547
  • [28] Evidence for the involvement of cytotoxic T lymphocytes specific for an HLA-A2-restricted H-Y antigen in graft-versus-leukemia effect on lymphoblastic leukemia cells.
    Takami, A
    Kondo, Y
    Nishimura, R
    Yachie, A
    Chuhjo, T
    Kotani, T
    Shiobara, S
    Nakao, S
    BLOOD, 2001, 98 (11) : 372B - 372B
  • [29] Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant
    G Weber
    U Gerdemann
    I Caruana
    B Savoldo
    N F Hensel
    K R Rabin
    E J Shpall
    J J Melenhorst
    A M Leen
    A J Barrett
    C M Bollard
    Leukemia, 2013, 27 : 1538 - 1547
  • [30] Isolation of CD4/CD8 positive regulatory T cells specific for a putative minor histocompatibility antigen, in a patient suffering from graft-versus-host-disease
    Eljaafari, A
    Michallet, M
    Farre, A
    Laurin, D
    Bienvenu, J
    Bernaud, J
    Gebuhrer, L
    Rigal, D
    TISSUE ANTIGENS, 2002, 59 : 126 - 127
12345